BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21514943)

  • 1. Xeroderma pigmentosum: a rare cause of chorea.
    Adamec D; Xie J; Poisson A; Broussolle E; Thobois S
    Rev Neurol (Paris); 2011 Nov; 167(11):837-40. PubMed ID: 21514943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xeroderma pigmentosum complementation group F: A rare cause of cerebellar ataxia with chorea.
    Carré G; Marelli C; Anheim M; Geny C; Renaud M; Rezvani HR; Koenig M; Guissart C; Tranchant C
    J Neurol Sci; 2017 May; 376():198-201. PubMed ID: 28431612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a primarily neurological phenotypic expression of xeroderma pigmentosum complementation group A in a Tunisian family.
    Messaoud O; Ben Rekaya M; Kefi R; Chebel S; Boughammoura-Bouatay A; Bel Hadj Ali H; Gouider-Khouja N; Zili J; Frih-Ayed M; Mokhtar I; Abdelhak S; Zghal M
    Br J Dermatol; 2010 Apr; 162(4):883-6. PubMed ID: 20199544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case report of xeroderma pigmentosum.
    Hawariat NW
    Ethiop Med J; 1991 Apr; 29(2):87-8. PubMed ID: 2060511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Xeroderma pigmentosum. A study in 40 Algerian patients].
    Bouadjar B; Aït-Belkacem F; Daya-Grosjean L; Sarasin A; Larbaoui SL; Ferhat R; Cherid MC; Bendissari A; Chouiter A; Bouzid K; Henni T; Hafiz A; Allouache A; Ysmail-Dahlouk M
    Ann Dermatol Venereol; 1996; 123(5):303-6. PubMed ID: 8761081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xeroderma pigmentosum: beyond skin cancer.
    Lichon V; Khachemoune A
    J Drugs Dermatol; 2007 Mar; 6(3):281-8. PubMed ID: 17373189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xeroderma pigmentosum: a review and case series.
    Butt FM; Moshi JR; Owibingire S; Chindia ML
    J Craniomaxillofac Surg; 2010 Oct; 38(7):534-7. PubMed ID: 20346687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A whole family affected by xeroderma pigmentosum: clinical and genetic particularities].
    Zghal M; Fazaa B; Zghal A; Mokhtar I; Sarasin A; Kamoun MR; Gharbi MR
    Ann Dermatol Venereol; 2003 Jan; 130(1 Pt 1):31-6. PubMed ID: 12605154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of melanoma in xeroderma pigmentosum.
    Rao TN; Bhagyalaxmi A; Ahmed K; Mohana Rao TS; Venkatachalam K
    Indian J Pathol Microbiol; 2009; 52(4):524-6. PubMed ID: 19805962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xeroderma pigmentosum: a Turkish case series.
    Gül U; Kiliç A; Gönül M; Cakmak SK; Soylu S
    Int J Dermatol; 2007 Nov; 46(11):1125-8. PubMed ID: 17988329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ophtalmologic manifestations of the xeroderma pigmentosum].
    Mseddi M; Sellami D; Elloumi Y; Aloulou Y; Kammoun B; Turki H; Feki J; Zahaf A
    Tunis Med; 2006 Sep; 84(9):542-4. PubMed ID: 17263199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of xeroderma pigmentosum with thrombasthenia.
    Hasanoğlu A; Gücüyener K; Tümer L; Gürsel T
    Turk J Pediatr; 1996; 38(2):261-4. PubMed ID: 8701496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new XPC gene splicing mutation has lead to the highest worldwide prevalence of xeroderma pigmentosum in black Mahori patients.
    Cartault F; Nava C; Malbrunot AC; Munier P; Hebert JC; N'guyen P; Djeridi N; Pariaud P; Pariaud J; Dupuy A; Austerlitz F; Sarasin A
    DNA Repair (Amst); 2011 Jun; 10(6):577-85. PubMed ID: 21482201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of xeroderma pigmentosum treated by oral etretinate].
    Hashimoto Y; Matsumoto M; Ohkuma N; Iizuka H; Chang HR; Ikenaga M
    Nihon Hifuka Gakkai Zasshi; 1990 Aug; 100(9):947-51. PubMed ID: 2259007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xeroderma pigmentosum: a case report and review of the literature.
    Feller L; Wood NH; Motswaledi MH; Khammissa RA; Meyer M; Lemmer J
    J Prev Med Hyg; 2010 Jun; 51(2):87-91. PubMed ID: 21155411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermoscopy of skin lesions in two patients with xeroderma pigmentosum.
    Malvehy J; Puig S; Martí-Laborda RM
    Br J Dermatol; 2005 Feb; 152(2):271-8. PubMed ID: 15727638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Xeroderma pigmentosum].
    Ueda M; Ichihashi M
    Nihon Rinsho; 1995 Nov; 53(11):2815-20. PubMed ID: 8538050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xeroderma pigmentosum: clonal chromosomal rearrangements in a pre-cancerous skin lesion.
    Chessa L; Nuzzo F; Stefanini M; Lagomarsini P; del Porto G
    Dis Markers; 1990; 8(3):125-36. PubMed ID: 2272148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xeroderma pigmentosum group E and DDB2, a smaller subunit of damage-specific DNA binding protein: proposed classification of xeroderma pigmentosum, Cockayne syndrome, and ultraviolet-sensitive syndrome.
    Itoh T
    J Dermatol Sci; 2006 Feb; 41(2):87-96. PubMed ID: 16325378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xeroderma pigmentosum group G with pellagroid rash: A rare presentation.
    Garg S; Garg K; Thakur V; Behera B
    Pediatr Dermatol; 2024; 41(1):150-152. PubMed ID: 37667072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.